CAPA Under Scrutiny: What FDA Inspectors Really Look For in 2026

A look into how FDA trains its inspectors to investigate your CAPA process.

FDA Inspectors seek clear root cause analysis and meaningful corrective actions.

Often, CAPA actions fail to prevent problems from recurring, and failure investigations do not accurately define the problem. Gain valuable insights into identifying root causes and developing appropriate corrective actions. Acquire skills necessary to ensure the systematic investigation of discrepancies as the pathway to prevent recurrence.  Learn how to meet the challenges of a 2026 inspection and what is needed to gain FDA’s trust. 

Applying AI within the CAPA process offers significant benefits. It enables streamlining, ensuring a shift from a reactive approach to a proactive, data-driven one. AI-powered QMS platforms like the Compliance Quest CAPA Module incorporate advanced automation, predictive analytics, and real-time data to detect potential quality issues early and identify the right issues to address, ensuring effective action plans.

 Key Take Aways

• Understand FDA’s Mindset
• Learn how to ensure FDA’s expectations are met
• Spot the Do’s & Don’ts
• Recognize what causes red flags to be raised
• Focus on necessary elements of your response to FDA inspection findings
• Highlight how AI Capabilities assist in identifying CAPA root cause
• Identify how AI-enhanced Compliance Quest CAPA Modules assist in preventing recurrence and allow detection of trends early on